Also

* GlaxoSmithKline won U.S. regulatory approval for a new version of its second-best-selling product, the antibiotic Augmentin, which is facing cheaper generic rivals in the U.S. Glaxo wants to use the new extended-release dose of the medicine as well as Augmentin ES, a version for earaches in children, to fend off challenges from Novartis’ Geneva Pharmaceuticals Inc. and other generic drug makers.

* Liberate Technologies Inc. fired 110 employees and said its fiscal first-quarter losses widened because demand slowed for its interactive-television software. The loss widened to $249.6 million, or $2.35 a share, from $77.9 million, or 74 cents, a year earlier. Revenue fell 40% to $10.3 million.

* Westcorp Inc., the holding company for Western Financial Bank, has withdrawn its proposal to buy the 16% of its auto loan subsidiary, WFS Financial Inc., it doesn’t already own. The companies couldn’t agree on how many Westcorp shares WFS shareholders should get for their shares, Westcorp said.